Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Lea

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Gastroenterology|June 10, 2006
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndromeRaj K Patel, Nicholas C Lea, Michael A Heneghan, et al.
Blood|July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromesAzim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2012
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantationRachel H Westbrook, Nicholas C Lea, Azim M Mohamedali, et al.
British Journal of Haematology|January 10, 2013
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosisAustin G Kulasekararaj, Alexander E Smith, Syed A Mian, et al.
Molecular and Cellular Biology|August 2, 2006
p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivoInês Soeiro, Azim Mohamedali, Hanna M Romanska, et al.
Blood|August 10, 2010
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic valueAlexander E Smith, Azim M Mohamedali, Austin Kulasekararaj, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Gastroenterology|June 10, 2006
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndromeRaj K Patel, Nicholas C Lea, Michael A Heneghan, et al.
Blood|July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromesAzim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2012
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantationRachel H Westbrook, Nicholas C Lea, Azim M Mohamedali, et al.
British Journal of Haematology|January 10, 2013
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosisAustin G Kulasekararaj, Alexander E Smith, Syed A Mian, et al.
Molecular and Cellular Biology|August 2, 2006
p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivoInês Soeiro, Azim Mohamedali, Hanna M Romanska, et al.
Blood|August 10, 2010
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic valueAlexander E Smith, Azim M Mohamedali, Austin Kulasekararaj, et al.
Pageof 2